GAMCO Investors’s Lifecore Biomedical LFCR Stock Holding History

GAMCO Investors’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$312K	Hold	83,800	–	–	﹤0.01%	887
2025 Q4	$685K	Sell	83,800 -700	-0.8%	-$5.18K	0.01%	737
2025 Q3	$622K	Hold	84,500	–	–	0.01%	755
2025 Q2	$686K	Hold	84,500	–	–	0.01%	752
2025 Q1	$595K	Sell	84,500 -1,500	-2%	-$9.32K	0.01%	649
2024 Q4	$639K	Sell	86,000 -1,500	-2%	-$9.58K	0.01%	657
2024 Q3	$431K	Buy	87,500 +6,300	+8%	+$32.9K	﹤0.01%	715
2024 Q2	$417K	Buy	81,200 +5,000	+7%	+$29.6K	﹤0.01%	715
2024 Q1	$405K	Sell	76,200 -300	-0.4%	-$2.15K	﹤0.01%	717
2023 Q4	$474K	Hold	76,500	–	–	0.01%	694
2023 Q3	$577K	Hold	76,500	–	–	0.01%	664
2023 Q2	$740K	Sell	76,500 -6,500	-8%	-$39.7K	0.01%	624
2023 Q1	$313K	Sell	83,000 -4,000	-5%	-$22.3K	﹤0.01%	751
2022 Q4	$564K	Buy	87,000 +8,000	+10%	+$65.9K	0.01%	683
2022 Q3	$702K	Buy	79,000 +2,000	+3%	+$20.3K	0.01%	628
2022 Q2	$768K	Buy	77,000 +2,000	+3%	+$19.8K	0.01%	628
2022 Q1	$869K	Buy	75,000 +2,000	+3%	+$22.3K	0.01%	633
2021 Q4	$810K	Buy	73,000 +13,918	+24%	+$135K	0.01%	664
2021 Q3	$545K	Buy	59,082 +12,582	+27%	+$137K	﹤0.01%	734
2021 Q2	$523K	Buy	+46,500	New	+$536K	﹤0.01%	754

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMCO Investors's LFCR Position: Q1 2026 in Review

GAMCO Investors held its Lifecore Biomedical (LFCR) position steady in Q1 2026 at 83,800 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #887.

GAMCO Investors first reported a position in LFCR in Q2 2021 and has held it in 20 quarters since. The position peaked at $869K in Q1 2022. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

GAMCO Investors held 83,800 shares of Lifecore Biomedical worth $312K as of Q1 2026.
GAMCO Investors left its Lifecore Biomedical share count unchanged in Q1 2026.
Lifecore Biomedical made up ﹤0.01% of GAMCO Investors's portfolio in Q1 2026, its #887 holding.
GAMCO Investors first reported a position in Lifecore Biomedical in Q2 2021 and has held it in 20 quarters since.
GAMCO Investors's Lifecore Biomedical position peaked at $869K in Q1 2022.
105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.